|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Landoni F, Maneo A, Colombo A, Placa F,
Milani R, Perego P, Favini G, Ferri L and Mangioni C: Randomised
study of radical surgery versus radiotherapy for stage Ib-IIa
cervical cancer. Lancet. 350:535–540. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neeman E and Ben-Eliyahu S: Surgery and
stress promote cancer metastasis: New outlooks on perioperative
mediating mechanisms and immune involvement. Brain Behav Immun. 30
(Suppl 1):S32–S40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hodson R: Precision medicine. Nature.
537:S492016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tannock IF and Hickman JA: Limits to
personalized cancer medicine. N Engl J Med. 375:1289–1294. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sano M, Suzuki M, Homma K, Hayashida K,
Tamura T, Matsuoka T, Katsumata Y, Onuki S and Sasaki J: Promising
novel therapy with hydrogen gas for emergency and critical care
medicine. Acute Med Surg. 5:113–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ge L, Yang M, Yang NN, Yin XX and Song WG:
Molecular hydrogen: A preventive and therapeutic medical gas for
various diseases. Oncotarget. 8:102653–102673. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohta S: Molecular hydrogen as a preventive
and therapeutic medical gas: Initiation, development and potential
of hydrogen medicine. Pharmacol Ther. 144:1–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tamura T, Suzuki M, Hayashida K, Kobayashi
Y, Yoshizawa J, Shibusawa T, Sano M, Hori S and Sasaki J: Hydrogen
gas inhalation alleviates oxidative stress in patients with
post-cardiac arrest syndrome. J Clin Biochem Nutr. 67:214–221.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Chao Y, Cheng P, Li N, Zheng H and
Yang Y: UPLC-QTOF/MS-based metabolomics reveals the protective
mechanism of hydrogen on mice with ischemic stroke. Neurochem Res.
44:1950–1963. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Y, Liu PY, Bao W, Chen SJ, Wu FS and
Zhu PY: Hydrogen inhibits endometrial cancer growth via a
ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway. BMC Cancer.
20:282020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang D, Wang L, Zhang Y, Zhao Y and Chen
G: Hydrogen gas inhibits lung cancer progression through targeting
SMC3. Biomed Pharmacother. 104:788–797. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harguindey S, Alfarouk K, Orozco JP,
Hardonniere K, Stanciu D, Fais S and Devesa J: A new and integral
approach to the etiopathogenesis and treatment of breast cancer
based upon its hydrogen ion dynamics. Int J Mol Sci. 21:11102020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen JB, Kong XF, Lv YY, Qin SC, Sun XJ,
Mu F, Lu TY and Xu KC: ‘Real world survey’ of hydrogen-controlled
cancer: A follow-up report of 82 advanced cancer patients. Med Gas
Res. 9:115–121. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andrews KR, Good JM, Miller MR, Luikart G
and Hohenlohe PA: Harnessing the power of RADseq for ecological and
evolutionary genomics. Nat Rev Genet. 17:81–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Masters JR: HeLa cells 50 years on: The
good, the bad and the ugly. Nat Rev Cancer. 2:315–319. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagaraj N, Wisniewski JR, Geiger T, Cox J,
Kircher M, Kelso J, Pääbo S and Mann M: Deep proteome and
transcriptome mapping of a human cancer cell line. Mol Syst Biol.
7:5482011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tavakolian S, Goudarzi H, Eslami G and
Faghihloo E: Transcriptional regulation of epithelial to
mesenchymal transition related genes by lipopolysaccharide in human
cervical cancer cell line HeLa. Asian Pac J Cancer Prev.
20:2455–2461. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Johrens K, Lazzerini L, Barinoff J,
Sehouli J and Cichon G: Mesothelin as a target for cervical cancer
therapy. Arch Gynecol Obstet. 299:211–216. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin Y, Ohkawara B, Ito M, Misawa N,
Miyamoto K, Takegami Y, Masuda A, Toyokuni S and Ohno K: Molecular
hydrogen suppresses activated Wnt/β-catenin signaling. Sci Rep.
6:319862016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kamalipooya S, Abdolmaleki P, Salemi Z,
Javani Jouni F, Zafari J and Soleimani H: Simultaneous application
of cisplatin and static magnetic field enhances oxidative stress in
HeLa cell line. In Vitro Cell Dev Biol Anim. 53:783–790. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Metsalu T and Vilo J: ClustVis: A web tool
for visualizing clustering of multivariate data using principal
component analysis and heatmap. Nucleic Acids Res. 43:W566–W570.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2^(-delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
26
|
Finkel T and Holbrook NJ: Oxidants,
oxidative stress and the biology of ageing. Nature. 408:239–247.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Costa V and Moradas-Ferreira P: Oxidative
stress and signal transduction in Saccharomyces cerevisiae:
Insights into ageing, apoptosis and diseases. Mol Aspects Med.
22:217–246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Trottier H and Burchell AN: Epidemiology
of mucosal human papillomavirus infection and associated diseases.
Public Health Genomics. 12:291–307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McBride AA: Oncogenic human
papillomaviruses. Philos Trans R Soc Lond B Biol Sci.
372:201602732017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Viarisio D, Gissmann L and Tommasino M:
Human papillomaviruses and carcinogenesis: Well-established and
novel models. Curr Opin Virol. 26:56–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
St Laurent J, Luckett R and Feldman S: HPV
vaccination and the effects on rates of HPV-related cancers. Curr
Probl Cancer. 42:493–506. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tornesello ML, Faraonio R, Buonaguro L,
Annunziata C, Starita N, Cerasuolo A, Pezzuto F, Tornesello AL and
Buonaguro FM: The role of microRNAs, long non-coding RNAs, and
circular RNAs in cervical cancer. Front Oncol. 10:1502020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Casarotto M, Fanetti G, Guerrieri R,
Palazzari E, Lupato V, Steffan A, Polesel J, Boscolo-Rizzo P and
Fratta E: Beyond microRNAs: Emerging role of other non-coding RNAs
in HPV-driven cancers. Cancers (Basel). 12:12462020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wen X, Liu S, Sheng J and Cui M: Recent
advances in the contribution of noncoding RNAs to cisplatin
resistance in cervical cancer. PeerJ. 8:e92342020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vojtechova Z and Tachezy R: The role of
miRNAs in virus-mediated oncogenesis. Int J Mol Sci. 19:12172018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gaur A, Jewell DA, Liang Y, Ridzon D,
Moore JH, Chen C, Ambros VR and Israel MA: Characterization of
microRNA expression levels and their biological correlates in human
cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
La Rosa FA, Pierce JW and Sonenshein GE:
Differential regulation of the c-myc oncogene promoter by the
NF-kappa B rel family of transcription factors. Mol Cell Biol.
14:1039–1044. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Perkins ND: Achieving transcriptional
specificity with NF-kappa B. Int J Biochem Cell Biol. 29:1433–1448.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vaupel P and Mayer A: Hypoxia in tumors:
Pathogenesis-related classification, characterization of hypoxia
subtypes, and associated biological and clinical implications. Adv
Exp Med Biol. 812:19–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou J, Schmid T, Schnitzer S and Brune B:
Tumor hypoxia and cancer progression. Cancer Lett. 237:10–21. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Semenza GL: Oxygen sensing,
hypoxia-inducible factors, and disease pathophysiology. Annu Rev
Pathol. 9:47–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wenger RH, Stiehl DP and Camenisch G:
Integration of oxygen signaling at the consensus HRE. Sci STKE.
2005:re122015.PubMed/NCBI
|
|
48
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
49
|
Seeber LM, Horree N, Vooijs MA, Heintz AP,
van der Wall E, Verheijen RH and van Diest PJ: The role of hypoxia
inducible factor-1alpha in gynecological cancer. Crit Rev Oncol
Hematol. 78:173–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Keith B, Johnson RS and Simon MC: HIF1α
and HIF2α: Sibling rivalry in hypoxic tumour growth and
progression. Nat Rev Cancer. 12:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Scholz CC and Taylor CT: Targeting the HIF
pathway in inflammation and immunity. Curr Opin Pharmacol.
13:646–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hervouet E, Cizkova A, Demont J,
Vojtiskova A, Pecina P, Franssen-van Hal NL, Keijer J, Simonnet H,
Ivanek R, Kmoch S, et al: HIF and reactive oxygen species regulate
oxidative phosphorylation in cancer. Carcinogenesis. 29:1528–1537.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hao Y, Yan Z, Zhang A, Hu S, Wang N, Luo
XG, Ma W, Zhang TC and He H: IL-6/STAT3 mediates the HPV18 E6/E7
stimulated upregulation of MALAT1 gene in cervical cancer HeLa
cells. Virus Res. 281:1979072020. View Article : Google Scholar : PubMed/NCBI
|
